Patents by Inventor Philippe-Alexandre GILBERT

Philippe-Alexandre GILBERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIVALENT INFLUENZA VACCINES COMPRISING RECOMBINANT HEMAGGLUTININ AND NEURAMINIDASE AND METHODS OF USING THE SAME
    Publication number: 20240277828
    Abstract: Disclosed herein are multivalent vaccine or immunogenic compositions comprising one or more recombinant influenza virus hemagglutinin (HA), one or more recombinant influenza virus neuraminidase (NA), and an optional adjuvant. Also disclosed are methods of using the vaccine or immunogenic composition.
    Type: Application
    Filed: May 2, 2024
    Publication date: August 22, 2024
    Inventors: Timothy ALEFANTIS, Mario BARRO, Anthony BYERS, Guadalupe CORTES-GARCIA, Philippe-Alexandre GILBERT, Harold KLEANTHOUS, Armaghan NAIK, Konstantin PUGACHEV, Saranya SRIDHAR, Thorsten VOGEL, William WARREN
  • MULTIVALENT INFLUENZA VACCINES
    Publication number: 20240269258
    Abstract: Disclosed are multivalent vaccine or immunogenic compositions comprising influenza virus hemagglutinin (HA) from standard of care influenza virus strains, or ribonucleic acid molecules encoding the same; and one or more influenza virus HA identified or designed by machine learning, or one or more ribonucleic acid molecules that encode the influenza virus HA identified or designed by machine learning. Also disclosed are methods of using the vaccine or immunogenic compositions.
    Type: Application
    Filed: April 5, 2024
    Publication date: August 15, 2024
    Inventors: Timothy ALEFANTIS, Mario BARRO, Anthony BYERS, Philip DAVIDSON, Maryann GIEL-MOLONEY, Philippe-Alexandre GILBERT, Harold KLEANTHOUS, Armaghan NAIK, Konstantin PUGACHEV, Saranya SRIDHAR, William WARREN, Konstantin ZELDOVICH